Interferon Type I

Displaying 1 - 6 of 6CSV
Vasou, A., Nightingale, K., Cetkovská, V., Scheler, J., Bamford, C. G. G., Andrejeva, J., Rowe, J. C., Swatek, K. N., Schwarz‐Linek, U., Randall, R. E., McLauchlan, J., Weekes, M. P., Bogunovic, D., & Hughes, D. J. (2025). ISG15‐Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in Humans. European Journal of Immunology, 55(2). Portico. https://doi.org/10.1002/eji.202451651
Publication Date
Rosain, J., Le Voyer, T., Liu, X., Gervais, A., Polivka, L., Cederholm, A., Berteloot, L., Parent, A. V., Pescatore, A., Spinosa, E., Minic, S., Kiszewski, A. E., Tsumura, M., Thibault, C., Esnaola Azcoiti, M., Martinovic, J., Philippot, Q., Khan, T., Marchal, A., … Casanova, J.-L. (2024). Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases. Journal of Experimental Medicine, 221(11). https://doi.org/10.1084/jem.20231152
Publication Date
Bobba, S., Chauhan, K. S., Akter, S., Das, S., Mittal, E., Mathema, B., Philips, J. A., & Khader, S. A. (2024). A protective role for type I interferon signaling following infection with Mycobacterium tuberculosis carrying the rifampicin drug resistance-conferring RpoB mutation H445Y. PLOS Pathogens, 20(4), e1012137. https://doi.org/10.1371/journal.ppat.1012137
Publication Date
Bobba, S., Howard, N. C., Das, S., Ahmed, M., Tang, L., Thirunavukkarasu, S., Larsen, M. H., Mathema, B., Divangahi, M., & Khader, S. A. (2023). Mycobacterium tuberculosis carrying the rifampicin drug-resistance-conferring rpoB mutation H445Y is associated with suppressed immunity through type I interferons. MBio, 14(5). https://doi.org/10.1128/mbio.00946-23
Publication Date
Jiang, W., Johnson, D., Adekunle, R., Heather, H., Xu, W., Cong, X., Wu, X., Fan, H., Andersson, L., Robertson, J., & Gisslén, M. (2022). COVID‐19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity. Journal of Medical Virology, 95(1). Portico. https://doi.org/10.1002/jmv.28134
Publication Date
Ning, W., Xu, W., Cong, X., Fan, H., Gilkeson, G., Wu, X., Hughes, H., & Jiang, W. (2022). COVID-19 mRNA vaccine BNT162b2 induces autoantibodies against type I interferons in a healthy woman. Journal of Autoimmunity, 132, 102896. https://doi.org/10.1016/j.jaut.2022.102896
Publication Date